SLI
2.157,39
PKT
+13,77
PKT
+0,64
%
Werbung
Analysen zu SLI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 01.06.20 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 29.05.20 | Roche buy | Jefferies & Company Inc. | |
| 29.05.20 | Roche overweight | JP Morgan Chase & Co. | |
| 27.05.20 | UBS Equal-Weight | Morgan Stanley | |
| 27.05.20 | UBS overweight | Morgan Stanley | |
| 27.05.20 | Zurich Insurance overweight | Morgan Stanley | |
| 27.05.20 | Givaudan buy | UBS AG | |
| 27.05.20 | Roche overweight | JP Morgan Chase & Co. | |
| 27.05.20 | Swiss Re Sector Perform | RBC Capital Markets | |
| 27.05.20 | Zurich Insurance Sector Perform | RBC Capital Markets | |
| 27.05.20 | UBS Neutral | JP Morgan Chase & Co. | |
| 27.05.20 | UBS overweight | JP Morgan Chase & Co. | |
| 26.05.20 | ams-OSRAM buy | Deutsche Bank AG | |
| 22.05.20 | ABB (Asea Brown Boveri) buy | UBS AG | |
| 22.05.20 | UBS buy | Goldman Sachs Group Inc. | |
| 22.05.20 | UBS buy | Goldman Sachs Group Inc. | |
| 21.05.20 | Holcim buy | Goldman Sachs Group Inc. | |
| 21.05.20 | Novartis Neutral | UBS AG | |
| 20.05.20 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 19.05.20 | Holcim overweight | Barclays Capital | |
| 19.05.20 | Swiss Re Hold | Jefferies & Company Inc. | |
| 18.05.20 | Givaudan buy | UBS AG | |
| 18.05.20 | Zurich Insurance overweight | JP Morgan Chase & Co. | |
| 18.05.20 | Swiss Re overweight | JP Morgan Chase & Co. | |
| 18.05.20 | UBS overweight | JP Morgan Chase & Co. | |
| 18.05.20 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 15.05.20 | Zurich Insurance buy | Goldman Sachs Group Inc. | |
| 15.05.20 | Zurich Insurance Hold | Deutsche Bank AG | |
| 15.05.20 | Roche kaufen | Barclays Capital | |
| 15.05.20 | Zurich Insurance buy | UBS AG | |
| 15.05.20 | Nestlé overweight | JP Morgan Chase & Co. | |
| 15.05.20 | Zurich Insurance overweight | JP Morgan Chase & Co. | |
| 14.05.20 | Givaudan Sell | Goldman Sachs Group Inc. | |
| 14.05.20 | Zurich Insurance buy | UBS AG | |
| 14.05.20 | Roche buy | UBS AG | |
| 14.05.20 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 14.05.20 | Zurich Insurance Outperform | Credit Suisse Group | |
| 14.05.20 | Zurich Insurance overweight | Barclays Capital | |
| 14.05.20 | Zurich Insurance overweight | Morgan Stanley | |
| 14.05.20 | ams-OSRAM Outperform | Credit Suisse Group |